EyePoint, Inc. has grown revenue −42% a year over three years and −26% a year over five. Revenue growth, 3-year annual rate: −42% (Biotechnology median +21%). Revenue growth, 5-year rate: −26%, growth has slowed since the five-year average. Years of annual history on file: 16, FY2009 to FY2025, as filed.

EYPTEyePoint, Inc.

HealthcareUSD

$5.00

$4.8752 weeks$18.85

Is it growing?

Is EYPT growing?

EyePoint, Inc. has grown revenue −42% a year over three years and −26% a year over five.

−42%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −26%
Revenue growth, 5-year rate · −42% over three · growth has slowed since the five-year average
Years of annual history on file: 16
Years of annual history on file · FY2009 to FY2025, as filed

Details›